Another possible mechanism of resistance could be an overactivation of the RAS/RAF/MEK/MAPK pathway in the resistant tumour cells that has often been shown to be associated with MPNST in NF-1 [4]. This evidence concerns the gene NF1 and malignant peripheral nerve sheath tumor.